Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

Pfizer Inc. closed 16.17% below its 52-week high of $31.54, which the company achieved on July 30th.

M&A activity in the F&B industry is set to rise in 2025, driven by favorable economic conditions and strategic acquisitions ...

Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.44 which represents a slight increase of $0.43 or 1.65% from the prior close of $26.01. The stock opened at $26.01 and touched a low ...

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the ...

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health agencies, among other moves that have sent waves through the biopharma industry.

Corporation, a biopharmaceutical company specializing in proprietary therapeutics with a market capitalization of $14 billion ...